The Story
Fakes. Underdosed compounds. Suppliers with no accountability, no transparency, and no way to verify what was actually in the vial. I spent years sourcing from multiple suppliers — experiencing firsthand what the difference between a legitimate research compound and a counterfeit one actually looks like. The education I needed to navigate that market didn't exist in plain English anywhere.
I built ReViaWell to close that gap. And I built ReViaLife to the supply standard I set for myself — before I ever offered it to anyone else. I use these compounds. My family uses them. My friends use them. That isn't a marketing line. It's the reason this company exists and the reason the standard we hold ourselves to isn't negotiable.
After 30 years in business development, corporate finance, biotechnology, and entrepreneurship — including work with companies at the intersection of pharmaceutical and consumer markets — I knew what a legitimate supply chain looked like. I also knew most of what was in the peptide market didn't come close to it. ReVia is the answer to that problem.